Is FAC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Automaker partnerships and validation milestones, with revenue (ttm) at ~$0 (pre-revenue). The bear case rests on factorial is pre-revenue and deeply unprofitable, with a large accumulated deficit and ongoing cash burn, so it depends on hitting commercialization milestones and likely raising more capital before running out of runway. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Factorial is pre-revenue and deeply unprofitable, with a large accumulated deficit and ongoing cash burn, so it depends on hitting commercialization milestones and likely raising more capital before running out of runway. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

Automaker partnerships and validation milestones. Factorial has joint development agreements with Mercedes-Benz, Stellantis, Hyundai, and Kia, which provide both technical credibility and a potential path to volume demand.

Factorial is pre-revenue and deeply unprofitable, with a large accumulated deficit and ongoing cash burn, so it depends on hitting commercialization milestones and likely raising more capital before running out of runway. The SPAC merger involved very high trust redemptions (reported around 83.5 percent), which pressures the share count and creates dilutive resale dynamics. Solid-state batteries remain unproven at mass automotive scale, and joint development agreements and MoUs (including those with SK On and Mitsui Kinzoku) do not guarantee binding, high-volume production orders. Competition from other solid-state developers and from continually improving lithium-ion cells is intense. The stock has been extremely volatile since listing: it trades near $4.74 versus a 52-week range of about $4.24 to $25.33, down about 54 percent year to date and 24 percent in the past month. As a recently de-SPACed, single-technology company, it carries meaningful execution, financing, and liquidity risk, and analyst coverage is thin (two analysts).

Factorial Energy develops solid-state battery technology for electric vehicles and other high-performance applications.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Automaker partnerships and validation milestones) stalling in the reported numbers rather than in the narrative, the risk above (factorial is pre-revenue and deeply unprofitable, with a large accumulated deficit and ongoing cash burn, so it depends on hitting commercialization milestones and likely raising more capital before running out of runway) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

FAC is the Nasdaq ticker for Factorial Energy Inc., a development-stage company that designs solid-state battery technology for electric vehicles, aerospace, and other applications. It began trading publicly in June 2026 after merging with the SPAC Cartesian Growth Corporation III.

Factorial develops solid-state battery cells through its FEST and Solstice platforms, aiming for higher energy density, faster charging, and better safety than conventional lithium-ion batteries. It works with automakers to validate and eventually commercialize these cells for EVs, and with manufacturing partners such as Mitsui Kinzoku and SK On to scale production.

No. Factorial is pre-revenue and reported a net loss of about $73.8 million for 2025 and about $70 million over the twelve months to June 2026, with an accumulated deficit of roughly $255.6 million at the end of 2025. It is a research-and-development stage company funding operations from raised capital rather than sales.